Product Details
Gemcitabine Sandoz 10 mg/mL Concentrate Solution for Infusion**
Gemcitabine (Gemcitabine Hydrochloride)10 mg/mL
Concentrate for solution for infusion
ROA
Intravenous
Applicant Name
Novartis Nigeria Limited
NRN
B4-7108
Status
Active
Composition
Each mL contains 11.4 mg Gemcitabine hydrochloride which corresponds to 10 mg of the active ingredient Gemcitabine. Each vial contains 10 mg/mL Gemcitabine (as hydrochloride) Each 20 mL vial contains 200 mg Gemcitabine (as hydrochloride). Each 50 mL vial contains 500 mg Gemcitabine (as hydrochloride). Each 100 mL vial contains 1000 mg Gemcitabine (as hydrochloride) Excipients with known effect: 20 mL vial: Sodium (as sodium acetate trihydrate and sodium hydroxide) 21.49 mg (0.93 mmol). 50 mL vial: Sodium (as sodium acetate trihydrate and sodium hydroxide) 53.74 mg (2.34 mmol). 100 mL vial: Sodium (as sodium acetate trihydrate and sodium hydroxide) 107.47 mg (4.67 mmol)
ATC Code
L01BC05
Product Category
Drugs
Marketing Category
Prescription-only Medicine (POM)
Packsize
200 mg/20 mL x 1's; 1000 mg/100 mL x 1's (in colourless vials)
Product Description
Concentrate for solution for infusion. Clear, colourless or almost colourless solution. Free from visible particles. pH: 5.0 – 6.0 Osmolality: 121.7 mOsmol/kg
Manufacturer Name
Fareva Unterach GmbH
Manufacturer Country
AUSTRIA
Approval Date
2023-05-25
Expiry Date
2028-05-24